Background. Debate continues over the management of the NO neck in head and
neck malignancy. Therefore, the possibility of performing sentinel node bi
opsy in these patients was investigated to formulate a method for the proce
dure.
Methods. Patients undergoing prophylactic or therapeutic neck dissections w
ere injected with either Patent Blue V dye alone or with blue dye and 99m-T
c labeled Albures. The latter group underwent preoperative lymphoscintigrap
hy. During surgery, blue stained lymphatics were followed to blue nodes, an
d a neoprobe was used to identify radioactive nodes.
Results. In 5 of 13 patients receiving blue dye,a blue node was identified,
but none contained tumor. Metastases were identified in other neck nodes i
n 3 of 5. Sentinel nodes were identified in 15 of 16 patients receiving dye
, and Albures. Sentinel node biopsy was accurate in 7 of 7 necks containing
impalpable metastases when all nodes had been evaluated after dissection.
Discussion. Sentinel node biopsy using blue dye and radiocolloid may prove
to be a reliable technique in the NO neck and warrants further investigatio
n. (C) 1999 John Wiley & Sons, Inc. Head Neck 21: 728-733, 1999.